Clinical

Dataset Information

0

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer


ABSTRACT: Phase II study of TAS-102 plus bevacizumab switch maintenance therapy in patients with mCRC

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2206138 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-08-26 | GSE275628 | GEO
2023-03-31 | GSE226221 | GEO
| 2646473 | ecrin-mdr-crc
| 92106 | ecrin-mdr-crc
| 91504 | ecrin-mdr-crc
| 2177942 | ecrin-mdr-crc
| 14404 | ecrin-mdr-crc
| PRJNA1170200 | ENA
| S-EPMC8637322 | biostudies-literature
| PRJNA1152270 | ENA